Reaching Beyond Disparity: Safely Improving Asthma Control in the At-Risk African-American Population

摘要: In the United States, substantial racial disparities exist in asthma prevalence, etiology, morbidity and mortality, particularly between African Americans white Americans. African-American patients with have inadequate access to appropriate healthcare, insufficient management guidance from their physicians poor adherence medications-all factors that may contribute disproportionate morbidity. Historically, been under-represented clinical studies, a paucity of data exists surrounding treatment response. One controversial study 2006 suggests an increased safety risk use long-acting β 2 -adrenergic agonists ILABAs) More recently, several studies evaluated LABAs combination ICS populations. This article reviews existing on outcomes, particular emphasis recently published short- long-term stUdies ICS/LABA products conducted populations moderate-to-severe asthma. Overall. evidence if are provided well-trained physicians, effective medications, control be overcome.